Home > List All Publishers > Current Partnering

Current Partnering

CurrentPartnering is an online provider of best practice, business information and intelligence for dealmakers. CurrentPartnering publish a series of reports, providing access to critical decision making and best practice intelligence from leaders in business development and licensing.
Best practice – reports providing insight into best practice and trends in partnering
Directories – detailed analysis of partnering interests and activity of companies worldwide
Contracts – obtain an insight and understanding of the terms acceptable to a potential partner
CurrentPartnering was established in 2007 by Wildwood Ventures Ltd to offer an objective and informal business tool for business development executives, providing an opportunity for the dissemination of the latest trends in partnering activity within the biopharma sector.

List of reports from Current Partnering

Manufacturing and Supply Partnering Terms and Agreements 1/1/2013 \| published by: Current Partnering ... analysis of how and why companies enter manufacturing and supply deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect ... \| more... Search inside this report	$2,995.00
Vaccine Partnering Terms and Agreements 1/1/2013 \| published by: Current Partnering ... Deal terms analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for vaccines The report provides a detailed understanding and analysis of how and why companies enter ... \| more... Search inside this report	$2,695.00
Practical Guide to Finding Partners 1/1/2013 \| published by: Current Partnering ... through the practical steps required to prepare for partnering, prepare supporting materials, identify and shortlist potential partners and opportunities, identifying and contacting the right person in the partner company, and managing of discussions through to ... \| more... Search inside this report	$1,295.00
Opthalmics Partnering Terms & Agreements 1/1/2013 \| published by: Current Partnering ... obtains a right or an option right to license the licensors opthalmics technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest opthalmics ... \| more... Search inside this report	$2,695.00
Merger and Acquisition Terms and Agreements 12/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter merger and acquisition deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect ... \| more... Search inside this report	$2,995.00
Asset Purchase Terms & Agreements 12/1/2012 \| published by: Current Partnering ... of how and why companies enter asset purchase deals. Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve ... \| more... Search inside this report	$2,695.00
Option and Evaluation Partnering Terms and Agreements 12/1/2012 \| published by: Current Partnering ... understand and analysis of how and why companies enter option and evaluation deals. The majority of deals are multicomponent whereby the licensor offers a right to option and evaluation the resultant product of the research ... \| more... Search inside this report	$2,695.00
Royalty Financing Partnering Terms and Agreements 12/1/2012 \| published by: Current Partnering ... agreement terms Royalty financing agreement structure Top royalty financing deals by value Most active Royalty financing dealmakers The Royalty Financing Terms and Agreements report provides comprehensive understanding and unprecedented access to the royalty financing agreements ... \| more... Search inside this report	$2,695.00
Monoclonal Antibody Partnering Terms and Agreements 12/1/2012 \| published by: Current Partnering ... to license the licensors monoclonal antibody technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest monoclonal antibody deals announced in the healthcare ... \| more... Search inside this report	$2,695.00
Co-promotion and Co-marketing Partnering Terms and Agreements 12/1/2012 \| published by: Current Partnering ... Revised and updated 7th edition, includes: Trends in co-promotion and co-marketing deals Co-promotion and co-marketing agreement structure Co-promotion and co-marketing contract documents Top co-promotion deals by value Top co-marketing deals by value Most active co-promotion ... \| more... Search inside this report	$2,695.00
Distribution Partnering Terms and Agreements 12/1/2012 \| published by: Current Partnering ... how and why companies enter distribution deals. The majority of deals are multicomponent whereby the licensor offers a right to distribute the resultant product of the research collaboration. There are also numerous pure distribution deals ... \| more... Search inside this report	$2,695.00
Infectives Vaccine Partnering Terms and Agreements 11/1/2012 \| published by: Current Partnering ... Trends in infectives vaccine dealmaking in the biopharma industry since 2007 Analysis of infectives vaccine deal structure Access to headline, upfront, milestone and royalty data Access to over 600 cancer vaccine deal records The leading ... \| more... Search inside this report	$1,995.00
Cancer Vaccine Partnering Agreements 11/1/2012 \| published by: Current Partnering ... how and why companies enter cancer vaccine partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors vaccine technology. These ... \| more... Search inside this report	$1,695.00
Cancer Monoclonal Antibody Partnering Agreements 11/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter cancer monoclonal antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors ... \| more... Search inside this report	$1,995.00
Antibody Partnering Agreements 11/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter antibody partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors antibody technology. ... \| more... Search inside this report	$2,695.00
Bioinformatics Partnering Terms & Agreements 10/1/2012 \| published by: Current Partnering ... analysis Partnering agreement structure Partnering contract documents Top deals by value Most active dealmakers Average deal terms for bioinformatics The Bioinformatics Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the bioinformatics ... \| more... Search inside this report	$2,695.00
Personalized Medicine Partnering Terms and Agreements 10/1/2012 \| published by: Current Partnering ... to the personalized medicine partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies enter personalized medicine partnering deals. The ... \| more... Search inside this report	$4,995.00
Dermatology Partnering Terms and Agreements 10/1/2012 \| published by: Current Partnering ... obtains a right or an option right to license the licensors bacterials technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest dermatology ... \| more... Search inside this report	$2,695.00
Diagnostics Partnering Terms and Agreements 10/1/2012 \| published by: Current Partnering ... how and why companies enter diagnostic partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors diagnostic technology or product candidates. These ... \| more... Search inside this report	$2,695.00
Biomarker Partnering Terms & Agreements 10/1/2012 \| published by: Current Partnering ... agreement structure Biomarker partnering contract documents Top biomarker deals by value Most active biomarker dealmakers The Biomarker Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the biomarker partnering deals and agreements ... \| more... Search inside this report	$2,695.00
Companion Diagnostics Partnering Terms & Agreements 10/1/2012 \| published by: Current Partnering ... understanding and analysis of how and why companies enter companion diagnostic partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ... \| more... Search inside this report	$2,695.00
Pediatrics Partnering Terms and Agreements 9/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter pediatrics partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors pediatrics technology. ... \| more... Search inside this report	$1,995.00
Immunology Partnering Terms and Agreements 9/1/2012 \| published by: Current Partnering ... analysis of how and why companies enter immunology partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the licensors immunology technology. ... \| more... Search inside this report	$2,695.00
Sexual Health Partnering Terms and Agreements 9/1/2012 \| published by: Current Partnering ... understanding and analysis of how and why companies enter sexual health partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license the ... \| more... Search inside this report	$1,995.00
Central Nervous System Partnering Terms and Agreements 9/1/2012 \| published by: Current Partnering ... a detailed understanding and analysis of how and why companies enter central nervous system partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right ... \| more... Search inside this report	$2,695.00

< prev 1 2 3 4 5 6 next >

Current Partnering

List of reports from Current Partnering

Research assistance

Join Alert Me now!